{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,31]],"date-time":"2026-08-31T12:36:19Z","timestamp":1788179779804,"version":"build-2803163510"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Research"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/j.phrs.2015.11.024","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T08:02:12Z","timestamp":1449216132000},"page":"328-339","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"special_numbering":"C","title":["Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson\u2019s disease"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1627-6795","authenticated-orcid":false,"given":"Br\u00edgida R.","family":"Pinho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara D.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Guedes-Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Leit\u00e3o-Rocha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara","family":"Quintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia","family":"Valent\u00e3o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula B.","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel M.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6040-5355","authenticated-orcid":false,"given":"Jorge M.A.","family":"Oliveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.phrs.2015.11.024_bib0005","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.pharmthera.2013.05.010","article-title":"Epigenetic targeting of histone deacetylase: therapeutic potential in Parkinson\u2019s disease?","volume":"140","author":"Harrison","year":"2013","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.phrs.2015.11.024_bib0010","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.nbd.2012.10.011","article-title":"Mitochondrial dysfunction and oxidative stress in Parkinson\u2019s disease and monogenic Parkinsonism","volume":"51","author":"Hauser","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2015.11.024_bib0015","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.nbd.2012.05.015","article-title":"The interplay of neuronal mitochondrial dynamics and bioenergetics: implications for Parkinson\u2019s disease","volume":"51","author":"Van Laar","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2015.11.024_bib0020","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.bbadis.2009.08.014","article-title":"Can cellular models revolutionize drug discovery in Parkinson\u2019s disease?","volume":"1792","author":"Sch\u00fcle","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2015.11.024_bib0025","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1476-5381.2011.01426.x","article-title":"Animal models of Parkinson\u2019s disease: a source of novel treatments and clues to the cause of the disease","volume":"164","author":"Duty","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0030","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.tins.2014.02.011","article-title":"Zebrafish models for translational neuroscience research: from tank to bedside","volume":"37","author":"Stewart","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.phrs.2015.11.024_bib0035","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1093\/brain\/awp108","article-title":"Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio)","volume":"132","author":"Flinn","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.phrs.2015.11.024_bib0040","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1111\/bph.12004","article-title":"The anti-cancer agent SU4312 unexpectedly protects against MPP(+) -induced neurotoxicity via selective and direct inhibition of neuronal NOS","volume":"168","author":"Cui","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0045","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/j.1471-4159.2008.05793.x","article-title":"MPTP and MPP+ target specific aminergic cell populations in larval zebrafish","volume":"108","author":"Sallinen","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2015.11.024_bib0050","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ntt.2004.06.014","article-title":"Sensitivity of zebrafish to environmental toxins implicated in Parkinson\u2019s disease","volume":"26","author":"S. Bretaud","year":"2004","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0055","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1111\/j.1460-9568.2005.03988.x","article-title":"Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP","volume":"21","author":"Lam","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.phrs.2015.11.024_bib0060","doi-asserted-by":"crossref","first-page":"e92905","DOI":"10.1371\/journal.pone.0092905","article-title":"Discovery of a natural product-like iNOS inhibitor by molecular docking with potential neuroprotective effects in vivo","volume":"9","author":"Zhong","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2015.11.024_bib0065","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.cbpa.2010.06.174","article-title":"Targeting epigenetic enzymes for drug discovery","volume":"14","author":"Copeland","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0070","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd4360","article-title":"Histone deacetylases and their inhibitors in cancer, neurological diseases and immune disorders","volume":"13","author":"Falkenberg","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.phrs.2015.11.024_bib0075","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/j.bbadis.2013.04.005","article-title":"Lysine deacetylases and mitochondrial dynamics in neurodegeneration","volume":"1832","author":"Guedes-Dias","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2015.11.024_bib0080","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.phrs.2010.01.011","article-title":"HDAC inhibitors and neurodegeneration: at the edge between protection and damage","volume":"62","author":"Dietz","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.phrs.2015.11.024_bib0085","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1523\/JNEUROSCI.5379-10.2011","article-title":"Histone deacetylase inhibitors preserve white matter structure and function during ischemia by conserving ATP and reducing excitotoxicity","volume":"31","author":"Baltan","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2015.11.024_bib0090","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1038\/nn.2471","article-title":"HDAC1 nuclear export induced by pathological conditions is essential for the onset of axonal damage","volume":"13","author":"Kim","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.phrs.2015.11.024_bib0095","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1093\/hmg\/ddt028","article-title":"Hdac6 deletion delays disease progression in the SOD1G93A mouse model of ALS","volume":"22","author":"Taes","year":"2013","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2015.11.024_bib0100","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1002\/emmm.201201923","article-title":"Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer\u2019s disease","volume":"5","author":"Govindarajan","year":"2013","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.phrs.2015.11.024_bib0105","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1038\/nm.2396","article-title":"HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot\u2013Marie\u2013Tooth disease","volume":"17","author":"d\u2019Ydewalle","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.phrs.2015.11.024_bib0110","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/bph.12186","article-title":"How mitochondrial dysfunction affects zebrafish development and cardiovascular function: an in vivo model for testing mitochondria-targeted drugs","volume":"169","author":"Pinho","year":"2013","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0115","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jsb.2005.06.002","article-title":"Feature point tracking and trajectory analysis for video imaging in cell biology","volume":"151","author":"Sbalzarini","year":"2005","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0120","doi-asserted-by":"crossref","first-page":"48246","DOI":"10.1074\/jbc.M408583200","article-title":"Role of the tetradecapeptide repeat domain of human histone deacetylase 6 in cytoplasmic retention","volume":"279","author":"Bertos","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2015.11.024_bib0125","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S0960-9822(00)00542-X","article-title":"Active maintenance of mHDA2\/mHDAC6 histone-deacetylase in the cytoplasm","volume":"10","author":"Verdel","year":"2000","journal-title":"Curr. Biol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1006\/jmbi.2001.4569","article-title":"Homo-oligomerisation and nuclear localisation of mouse histone deacetylase 1","volume":"308","author":"Taplick","year":"2001","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0135","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0092-8674(03)00939-5","article-title":"The deacetylase HDAC6 regulates aggresome formation and cell viability in response to misfolded protein stress","volume":"115","author":"Kawaguchi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.phrs.2015.11.024_bib0140","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.aquatox.2014.10.011","article-title":"Impact of co-exposure with lead and decabromodiphenyl ether (BDE-209) on thyroid function in zebrafish larvae","volume":"157","author":"Zhu","year":"2014","journal-title":"Aquat. Toxicol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0145","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.phrs.2015.11.024_bib0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/zeb.2012.0841","article-title":"Development of an assay for high-throughput energy expenditure monitoring in the zebrafish","volume":"10","author":"Renquist","year":"2013","journal-title":"Zebrafish"},{"key":"10.1016\/j.phrs.2015.11.024_bib0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.molbrainres.2004.09.017","article-title":"The MPTP model of Parkinson\u2019s disease","volume":"134","author":"Smeyne","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.phrs.2015.11.024_bib0160","doi-asserted-by":"crossref","first-page":"e77548","DOI":"10.1371\/journal.pone.0077548","article-title":"Functional characterisation of the maturation of the blood-brain barrier in larval zebrafish","volume":"8","author":"Fleming","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.phrs.2015.11.024_bib0165","doi-asserted-by":"crossref","first-page":"2484","DOI":"10.1016\/j.bbadis.2015.08.012","article-title":"HDAC6 inhibition induces mitochondrial fusion, autophagic flux and reduces diffuse mutant huntingtin in striatal neurons","volume":"1852","author":"Guedes-Dias","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2015.11.024_bib0170","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0887-2333(01)00014-5","article-title":"Evaluation of hepatic subcellular fractions for Alamar blue and MTT reductase activity","volume":"15","author":"Gonzalez","year":"2001","journal-title":"Toxicol. In Vitro"},{"key":"10.1016\/j.phrs.2015.11.024_bib0175","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/dneu.20911","article-title":"Dopaminergic and noradrenergic circuit development in zebrafish","volume":"72","author":"Schweitzer","year":"2012","journal-title":"Dev. Neurobiol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0180","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ydbio.2007.11.012","article-title":"Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish","volume":"314","author":"Wen","year":"2008","journal-title":"Dev. Biol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0185","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.nbd.2011.05.016","article-title":"Evaluation of spontaneous propulsive movement as a screening tool to detect rescue of Parkinsonism phenotypes in zebrafish models","volume":"44","author":"Farrell","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.phrs.2015.11.024_bib0190","doi-asserted-by":"crossref","first-page":"5512","DOI":"10.1523\/JNEUROSCI.5548-10.2011","article-title":"Dopamine D2 receptor activity modulates Akt signaling and alters GABAergic neuron development and motor behavior in zebrafish larvae","volume":"31","author":"Souza","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.phrs.2015.11.024_bib0195","doi-asserted-by":"crossref","first-page":"e1222","DOI":"10.1038\/cddis.2014.166","article-title":"Transcriptional and metabolic adaptation of human neurons to the mitochondrial toxicant MPP(+)","volume":"5","author":"Krug","year":"2014","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2015.11.024_bib0200","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.neuro.2007.02.008","article-title":"Biphasic mechanism of the toxicity induced by 1-methyl-4-phenylpyridinium ion (MPP+) as revealed by dynamic changes in glucose metabolism in rat brain slices","volume":"28","author":"Maruoka","year":"2007","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.phrs.2015.11.024_bib0205","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/cne.21345","article-title":"Ultrastructural analysis of aminoglycoside-induced hair cell death in the zebrafish lateral line reveals an early mitochondrial response","volume":"502","author":"Owens","year":"2007","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0210","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.bbagen.2011.08.007","article-title":"Overexpression of TFAM, NRF-1 and myr-AKT protects the MPP(+)-induced mitochondrial dysfunctions in neuronal cells","volume":"1820","author":"Piao","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.phrs.2015.11.024_bib0215","doi-asserted-by":"crossref","first-page":"e312","DOI":"10.1038\/cddis.2012.46","article-title":"Impaired mitochondrial biogenesis contributes to depletion of functional mitochondria in chronic MPP+ toxicity: dual roles for ERK1\/2","volume":"3","author":"Zhu","year":"2012","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.phrs.2015.11.024_bib0220","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.neuroscience.2013.04.037","article-title":"Sodium butyrate improves locomotor impairment and early mortality in a rotenone-induced Drosophila model of Parkinson\u2019s disease","volume":"246","author":"St Laurent","year":"2013","journal-title":"Neuroscience"},{"key":"10.1016\/j.phrs.2015.11.024_bib0225","doi-asserted-by":"crossref","first-page":"14941","DOI":"10.1074\/jbc.M110.211029","article-title":"Phenylbutyrate up-regulates the DJ-1 protein and protects neurons in cell culture and in animal models of Parkinson disease","volume":"286","author":"Zhou","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2015.11.024_bib0230","doi-asserted-by":"crossref","first-page":"3012","DOI":"10.1093\/hmg\/ddl243","article-title":"Alpha-synuclein acts in the nucleus to inhibit histone acetylation and promote neurotoxicity","volume":"15","author":"Kontopoulos","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.phrs.2015.11.024_bib0235","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","article-title":"Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes","volume":"11","author":"Chen","year":"2006","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.phrs.2015.11.024_bib0240","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.neurobiolaging.2014.04.029","article-title":"Histone deacetylase 6 regulates cytotoxic alpha-synuclein accumulation through induction of the heat shock response","volume":"35","author":"Du","year":"2014","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.phrs.2015.11.024_bib0245","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/j.1471-4159.2011.07180.x","article-title":"HDAC6 regulates aggresome-autophagy degradation pathway of alpha-synuclein in response to MPP+-induced stress","volume":"117","author":"Su","year":"2011","journal-title":"J. Neurochem."},{"key":"10.1016\/j.phrs.2015.11.024_bib0250","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1471-2164-12-24","article-title":"The epigenetic regulator histone deacetylase 1 promotes transcription of a core neurogenic programme in zebrafish embryos","volume":"12","author":"Harrison","year":"2011","journal-title":"BMC Genomics"},{"key":"10.1016\/j.phrs.2015.11.024_bib0255","doi-asserted-by":"crossref","first-page":"18311","DOI":"10.1074\/jbc.M110.133603","article-title":"The developmental regulator protein Gon4l associates with protein YY1, co-repressor Sin3a, and histone deacetylase 1 and mediates transcriptional repression","volume":"286","author":"Lu","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.phrs.2015.11.024_bib0260","doi-asserted-by":"crossref","first-page":"e1002265","DOI":"10.1371\/journal.pgen.1002265","article-title":"An iterative genetic and dynamical modelling approach identifies novel features of the gene regulatory network underlying melanocyte development","volume":"7","author":"Greenhill","year":"2011","journal-title":"PLoS Genet."},{"key":"10.1016\/j.phrs.2015.11.024_bib0265","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/dvdy.20168","article-title":"Histone deacetylase 1 (HDAC-1) required for the normal formation of craniofacial cartilage and pectoral fins of the zebrafish","volume":"231","author":"Pillai","year":"2004","journal-title":"Dev. Dyn."},{"key":"10.1016\/j.phrs.2015.11.024_bib0270","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.ydbio.2008.06.040","article-title":"Organ-specific requirements for Hdac1 in liver and pancreas formation","volume":"322","author":"Noel","year":"2008","journal-title":"Dev. Biol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0275","doi-asserted-by":"crossref","first-page":"4142","DOI":"10.1038\/emboj.2011.298","article-title":"Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin","volume":"30","author":"Kaluza","year":"2011","journal-title":"EMBO J."},{"key":"10.1016\/j.phrs.2015.11.024_bib0280","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1096\/fj.13-246470","article-title":"Fam65b is important for formation of the HDAC6-dysferlin protein complex during myogenic cell differentiation","volume":"28","author":"Balasubramanian","year":"2014","journal-title":"FASEB J."},{"key":"10.1016\/j.phrs.2015.11.024_bib0285","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrm2346","article-title":"The Rpd3\/Hda1 family of lysine deacetylases: from bacteria and yeast to mice and men","volume":"9","author":"Yang","year":"2008","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.phrs.2015.11.024_bib0290","doi-asserted-by":"crossref","first-page":"10842","DOI":"10.1021\/ja102758v","article-title":"Rational design and simple chemistry yield a superior, neuroprotective HDAC6 inhibitor, tubastatin A","volume":"132","author":"Butler","year":"2010","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.phrs.2015.11.024_bib0295","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1124\/jpet.103.055541","article-title":"Identification of novel isoform-selective inhibitors within class I histone deacetylases","volume":"307","author":"Hu","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.phrs.2015.11.024_bib0300","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0896-6273(00)80246-9","article-title":"Imaging the functional organization of zebrafish hindbrain segments during escape behaviors","volume":"17","author":"O\u2019Malley","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2015.11.024_bib0305","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.brainresrev.2004.06.010","article-title":"Dynamics of electrical transmission at club endings on the Mauthner cells","volume":"47","author":"Pereda","year":"2004","journal-title":"Brain Res. Brain Res. Rev."},{"key":"10.1016\/j.phrs.2015.11.024_bib0310","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.neuron.2012.05.035","article-title":"Visual input modulates audiomotor function via hypothalamic dopaminergic neurons through a cooperative mechanism","volume":"75","author":"Mu","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.phrs.2015.11.024_bib0315","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbrc.2014.05.134","article-title":"Involvement of transcription factor XBP1s in the resistance of HDAC6 inhibitor Tubastatin A to superoxidation via acetylation-mediated proteasomal degradation","volume":"450","author":"Zhang","year":"2014","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.phrs.2015.11.024_bib0320","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/npp.2013.207","article-title":"Antidepressant-like properties of novel HDAC6-selective inhibitors with improved brain bioavailability","volume":"39","author":"Jochems","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.phrs.2015.11.024_bib0325","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.bbr.2011.12.016","article-title":"Measuring thigmotaxis in larval zebrafish","volume":"228","author":"Schn\u00f6rr","year":"2012","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.phrs.2015.11.024_bib0330","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1038\/nn.3354","article-title":"Class I HDAC inhibition blocks cocaine-induced plasticity by targeted changes in histone methylation","volume":"16","author":"Kennedy","year":"2013","journal-title":"Nat. Neurosci."}],"container-title":["Pharmacological Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815002819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043661815002819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T02:21:49Z","timestamp":1537150909000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043661815002819"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1]]},"references-count":66,"alternative-id":["S1043661815002819"],"URL":"https:\/\/doi.org\/10.1016\/j.phrs.2015.11.024","relation":{},"ISSN":["1043-6618"],"issn-type":[{"value":"1043-6618","type":"print"}],"subject":[],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pharmacological modulation of HDAC1 and HDAC6 in vivo in a zebrafish model: Therapeutic implications for Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.phrs.2015.11.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}